re: Ann: Investec Wentworth sell down shareho... Well, that answers that question. And it would be fair to say that that is a fairly positive view on VOC from the fund manager.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%